Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Dash

Showing results (51-60 of 64) with videos related to

Pageof 7
Sort By:
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|May 7, 2013
Emergence of a novel lineage genetically divergent from the predominant Ind2001 lineage of serotype O foot-and-mouth disease virus in IndiaSaravanan Subramaniam, Aniket Sanyal, Jajati K Mohapatra, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 29, 2002
A murine model of CML blast crisis induced by cooperation between BCR/ABL and NUP98/HOXA9Ajeeta B Dash, Ifor R Williams, Jeffery L Kutok, et al.
Investigational New Drugs|May 22, 2018
Phase Ib study of pevonedistat, a NEDD8-activating enzyme inhibitor, in combination with docetaxel, carboplatin and paclitaxel, or gemcitabine, in patients with advanced solid tumorsA Craig Lockhart, Todd M Bauer, Charu Aggarwal, et al.
Blood Cancer Journal|January 11, 2023
A pooled analysis of outcomes according to cytogenetic abnormalities in patients receiving ixazomib- vs placebo-based therapy for multiple myelomaWee-Joo Chng, Sagar Lonial, Gareth J Morgan, et al.
Transboundary and Emerging Diseases|March 3, 2017
Quantitative characteristics of the foot-and-mouth disease carrier state under natural conditions in IndiaS S Hayer, R Ranjan, J K Biswal, et al.
Preventive Veterinary Medicine|March 19, 2021
Foot and Mouth Disease (FMD) incidence in cattle and buffaloes and its associated farm-level economic costs in endemic IndiaGovindaraj G, Ganesh Kumar B, Krishnamohan A, et al.
Blood|September 21, 2022
MRD dynamics during maintenance for improved prognostication of 1280 patients with myeloma in the TOURMALINE-MM3 and -MM4 trialsBruno Paiva, Irene Manrique, Meletios A Dimopoulos, et al.
The Journal of the Association of Physicians of India|May 9, 2002
Multicentric clinical trials for safety and efficacy evaluation of alpha;beta arteether in complicated P. falciparum malariaO P Asthana, J S Srivastava, T K Pandey, et al.
Blood|January 20, 2018
Pevonedistat, a first-in-class NEDD8-activating enzyme inhibitor, combined with azacitidine in patients with AMLRonan T Swords, Steven Coutre, Michael B Maris, et al.
Hemasphere|November 15, 2024
Preclinical evaluation of the CD38-targeting engineered toxin body MT-0169 against multiple myelomaWassilis S C Bruins, Rosa Rentenaar, John Newcomb, et al.
Pageof 7

Showing results (51-60 of 64) with videos related to

Sort By:
Pageof 7
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|May 7, 2013
Emergence of a novel lineage genetically divergent from the predominant Ind2001 lineage of serotype O foot-and-mouth disease virus in IndiaSaravanan Subramaniam, Aniket Sanyal, Jajati K Mohapatra, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 29, 2002
A murine model of CML blast crisis induced by cooperation between BCR/ABL and NUP98/HOXA9Ajeeta B Dash, Ifor R Williams, Jeffery L Kutok, et al.
Investigational New Drugs|May 22, 2018
Phase Ib study of pevonedistat, a NEDD8-activating enzyme inhibitor, in combination with docetaxel, carboplatin and paclitaxel, or gemcitabine, in patients with advanced solid tumorsA Craig Lockhart, Todd M Bauer, Charu Aggarwal, et al.
Blood Cancer Journal|January 11, 2023
A pooled analysis of outcomes according to cytogenetic abnormalities in patients receiving ixazomib- vs placebo-based therapy for multiple myelomaWee-Joo Chng, Sagar Lonial, Gareth J Morgan, et al.
Transboundary and Emerging Diseases|March 3, 2017
Quantitative characteristics of the foot-and-mouth disease carrier state under natural conditions in IndiaS S Hayer, R Ranjan, J K Biswal, et al.
Preventive Veterinary Medicine|March 19, 2021
Foot and Mouth Disease (FMD) incidence in cattle and buffaloes and its associated farm-level economic costs in endemic IndiaGovindaraj G, Ganesh Kumar B, Krishnamohan A, et al.
Blood|September 21, 2022
MRD dynamics during maintenance for improved prognostication of 1280 patients with myeloma in the TOURMALINE-MM3 and -MM4 trialsBruno Paiva, Irene Manrique, Meletios A Dimopoulos, et al.
The Journal of the Association of Physicians of India|May 9, 2002
Multicentric clinical trials for safety and efficacy evaluation of alpha;beta arteether in complicated P. falciparum malariaO P Asthana, J S Srivastava, T K Pandey, et al.
Blood|January 20, 2018
Pevonedistat, a first-in-class NEDD8-activating enzyme inhibitor, combined with azacitidine in patients with AMLRonan T Swords, Steven Coutre, Michael B Maris, et al.
Hemasphere|November 15, 2024
Preclinical evaluation of the CD38-targeting engineered toxin body MT-0169 against multiple myelomaWassilis S C Bruins, Rosa Rentenaar, John Newcomb, et al.
Pageof 7